AANS Virtual 2020: Trauma Bundle
The Trauma Bundle provides current, relevant theory and discussion surrounding trauma in neurosurgery. Get instant access and earn up to 5.25 CME in trauma, while bettering your practice with a wealth of knowledge shared through three courses and 24 presentations included in the bundle.
The Trauma Session offers a current overview of neurotrauma, critical care and sports medicine; the Return-to-play after Sports Injury II explores the neurosurgeon's role in clearing athletes with spine injuries for a return to sports; and The Use of Opioids in Neurosurgical Practice course is a timely look at updates to opioid treatment policies.
Pricing
AANS Member | $99 |
Non-member | $149 |
Courses Included
- Trauma Session
- Return-to-play after Sports Injury II: Spine Injury
- The Use of Opioids in Neurosurgical Practice: How to be Safe, Effective and Compliant with New Prescribing Laws
Spine and Tumor bundles also available.
-
Trauma Session
Includes CreditsHear the latest research in trauma, critical care and sports medicine as well as recommended practice management strategies. AANS Member: $49 | Non-member: $79
Faculty address research in trauma, critical care and sports medicine as well as practice management strategies that lead to improved patient care. Trauma is the subspecialty that involves the most frequent life-saving work and staying up-to-date on the latest in the field is vital. Earn 2 CME, while growing your knowledge of trauma.
Pricing
AANS Member $49 Non-member $79 Faculty
Faculty
- Jonathon J. Parker MD, PhD
- Aladine Abdalla Elsamadicy, BE, MD
- Brett Eric Sterk
- Ryan Chiu
- Nida Fatima, MBBS
- Christian Andrew Bowers, MD
- Alicia Everitt
- John J. Y. Zhang
- Remi A. Kessler
- Benjamin Andrew Davidson, MD
- Jean X Jiang
- James Gregory Malcolm
- Eric T. Quach
- Shane Shahrestani
- Mark D. Johnson
Learning Objectives
- Discuss research updates in trauma neurosurgery.
- Apply updates in trauma neurosurgery to practice.
Accreditation
The AANS designates this internet enduring material activity for a maximum of 2 AMA PRA Category 1 Credits™.
Disclosure Information
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.
Name
Relationship/Company
Jean X Jiang
Board, Trustee, Officer, Leadership position that could affect an entities' finances, Consultant Fees, Grants/Research Support, Stock Shareholder (purchased direct, i.e. not through Mutual Fund, retirement package, etc.), - AlaMab Therapeutics Inc
Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.
Disclaimer
The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care or course of management does not imply endorsement or disapproval of products.
Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients served.
Accreditation Designation
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AANS designates this internet enduring material activity for a maximum of 2 AMA PRA Category 1 Credits.™
Physicians should claim only credit commensurate with the extent of their participation in the activity.
Term of approval is for three years, beginning from 05/15/2020 until 05/15/2023.
© 2020 American Association of Neurological Surgeons
-
Return-to-play After Sports Injury II: Spine Injury
Includes CreditsThis webinar addresses the neurosurgeon's role in evaluating and clearing children, high school athletes, college athletes and professional athletes with spine injuries. AANS Member: Free| Non-member: $49
The identification and management of sports-related injuries has received recent attention in the press and in neurosurgical literature. This course addresses the neurosurgeon's role in evaluating and clearing children, high school athletes, college athletes and professional athletes with spine injuries.
Pricing
AANS Member Free Non-member $49 Faculty
Principal Faculty
- Michael W. Groff, MD, FAANS
- Christina Marie Notarianni, MD, FAANS
- Daniel C. Lu, MD, PhD, FAANS
- Douglas L. Brockmeyer, MD, FAANS
- Srinivas K. Prasad, MD, FAANS
Learning Objectives
Upon completion of this activity, participants should be able to:
- Explain the standard tests and techniques for evaluating the injured athlete.
- Describe the pathophysiology of sports-related injuries.
- Apply the data and expert opinion on return-to-play guidelines to practice.
CME Accreditation
The AANS designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™.
Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.
Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.
Disclosure Information
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.
Name
Relationship/Company
Michael W. Groff, MD, FAANS Consultant Fees – Depuy Spine, EBI Spine Grants/Research Support – Depuy Spine Other Financial Support – Depuy Spine, SpineArt, Nuvasive Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.
Christina Marie Notarianni, MD, FAANS
Daniel C. Lu, MD, PhD, FAANS
Douglas L. Brockmeyer, MD, FAANS
Srinivas K. Prasad, MD, FAANS
Accreditation
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AANS designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was published in 5/19/2020. Credit may be obtained until 5/19/2023.
-
The Use of Opioids in Neurosurgical Practice: How to be Safe, Effective and Compliant with New Prescribing Laws
Includes CreditsThis online course provides an update for any neurosurgeon, resident, fellow, nurse practitioner or physician assistant who utilizes opioids in neurosurgical practice. AANS Member: Free | Non-member: $49
This online course provides an update for any neurosurgeon, resident, fellow, nurse practitioner or physician assistant who utilizes opioids in neurosurgical practice. It includes information on the pharmacology and clinical evidence supporting opioids and related medications in neurosurgery patients, how to provide these medications safely to neurosurgical patients – even in those who are chronic opioid users – and how new health care legislation affects the use of opioids in neurosurgical practice.
Pricing
AANS Member Free Non-member $49 Faculty
Principal Faculty
- Christopher J. Winfree, MD, FAANS
- Joshua M. Rosenow, MD, FAANS
- Jakun Willard Ing, MD
- Jason M. Schwalb, MD, FAANS
Learning Objectives
Upon completion of this activity, participants should be able to:
- Discuss the pharmacology and pharmacokinetics of opioids used in neurosurgical practice, including related medications used, such as naloxone and buprenorphine.
- Recognize the clinical evidence and guidelines for the use of these medications in neurosurgical patients.
- Apply the perioperative management of neuropathic and nociceptive pain in neurosurgical patients, including in patients who are chronic opioid users.
- Describe recent opioid legislation and the implications of these new laws on opioid prescribing in neurosurgical practice.
CME Accreditation
The AANS designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™.
Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.
Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.
Disclosure Information
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.
Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.
Name
Relationship/Company
Joshua M. Rosenow, MD, FAANS, FACS Consultant Fees – Boston Scientific Neuromodulation, Voyager therapeutics Other Financial Support – Boston Scientific Neuromodulation Jason M. Schwalb, MD, FAANS, FACS Grants/Research Support – Stimwave, Medtronic, Guidant, LLC Other Financial Support – Blue Cross Blue Shield of Michigan Consultant Fees – Bluerock Expert Medical Opinion Services Income - Neuros Grants/Research Support – Neuros Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.
Christopher J. Winfree, MD, FAANS
Jakun Willard Ing, MD
Accreditation
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AANS designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was published in 5-19-2020. Credit may be obtained until 5-19-2023.
Disclaimer
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources, and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care, or course of management does not imply endorsement or disapproval of products.
Please note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients we serve.
Accreditation
The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The AANS designates this enduring material for a maximum of 5.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity was published in 7/17/2020. Credit may be obtained until 7/17/2023.